ONCOTYPE DX DCIS ASSAY

Newly diagnosed invasive breast cancer patients with Stage I, II, or III (T3, N1) ER-positive, HER2-negative breast cancer.

Available via

Lab Visit

Contains

1 parameters

Earliest reports in

20 Working Days

Test details
Preparations

No special preparations needed

Test included
ONCOTYPE DX DCIS ASSAY includes 1 parameter

  • Oncotype Dx Dcis Assay

Test code

G866

Specimen vol. and vacutainer information
SpecimenVacutainerVolume
BlocksOthers

Collection instructions

Age, Gender & Clinical History are Mandatory.

Specimen rejection criteria

Test run frequency

Every Day TIME - 10:30

Turn around time

20 Working Days

Performing locations

Department

  • Advanced Molecular Diagnostics R&d

CPT and Loinc codes

ONCOTYPE DX DCIS ASSAY

355000